Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
The UK's Accelerated Access Collaborative (AAC) has filled the hole left by ex-Glaxo CEO Andrew Witty's recent departure with public-sector stalwart Lord Ara Darzi. This should restore some certainty to the initiative when the UK health-care sector was thrown into confusion by the promise of £20bn more NHS funding and by ongoing Brexit machinations with uncertain impact.
Latest From Market Access
Even though the Turkish government has settled some of the sizeable debt owed by hospitals to medical device and pharmaceutical suppliers, industry continues to be disgruntled over not being remunerated for the full amount owed and there continues to be wrangling over how the situation should be resolved.
Proposals for the 2019 Medicare physician fee schedule and clinical laboratory fee schedule (CLFS) released July 12 include reforms designed to relax reporting requirements for providers of health services, and take advantage of emerging telemedicine technologies. See what US Centers for Medicare and Medicaid Services Administrator Seema Verma said about it here.
The US Medicare agency has proposed several changes to the status quo in its planned 2019 Medicare physician fee schedule and clinical laboratory fee schedule that will impact reimbursements for telehealth services, the advanced imaging industry and clinical laboratories.
Durable medical equipment suppliers will have the flexibility to provide products to any Medicare beneficiaries without having to win a competitive bidding contract beginning Jan. 1. That state-of-play will last until CMS reinitiates the paused bidding program currently undergoing reforms.
Digital tools and maximizing the data derived from them will influence the delivery of health care in ways and to extents yet unknown. Andrew Davies, market access director for UK industry group ABHI, explains the industry's planning around this, and calls for a rethink on innovation market access structures, which are still failing to meet industry's needs.
The UK is undergoing big changes in its health-care system and medical device procurement in particular. Association of British HealthTech Industries' Nishan Sunthares highlights one of the device industry's hoped-for outcomes here.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.